EN PL

MHRA: Marketing Authorisation applications for medicines using the Decentralised procedure (DCP) with the UK as Reference Member State (RMS): New or earlier slots available in all therapeutic areas

27.07.2009
As a result of cancellations and delays in submissions for booked DCP slots, MHRA has some capacity in all therapeutic areas to offer new or earlier slots to applicants for procedures commencing from July 2009 onwards.